Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of TAK-128, once daily
(QD), in treating subjects with diabetic peripheral neuropathy.